A Multicenter, Double-Blind, Placebo Controlled,Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral Montelukast Versus Placebo in Persistent Asthma Which is Also Active During Allergy Seasons in Pediatric Patients With Seasonal Aeroallergen Sensitivity
Latest Information Update: 05 May 2022
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Sponsors Merck & Co; Organon
- 12 Feb 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 11 Oct 2007 Status changed from recruiting to in progress.
- 02 Feb 2007 New trial centre added.